CAYSIE CLARY: Open Payments
NPI 1407223415 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 16 payments from 10 companies in 2025. Trend: 2023 $133 · 2024 $204 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| PFIZER INC. | 2 | $34 |
| Amgen Inc. | 2 | $31 |
| Abbott Laboratories | 2 | $29 |
| Exact Sciences Corporation | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: ROTATEQ, TRELEGY ELLIPTA, NURTEC ODT, OTEZLA, FREESTYLE LIBRE 3, VRAYLAR, Cologuard Collection Kit, EOHILIA.
Industry payments across AZ — which companies pay providers there.
